Tyrosine kinase-2 gene polymorphisms are associated with ulcerative colitis and Crohn's disease in Turkish Population

Clinics and Research in Hepatology and Gastroenterology

Volumn 39, Issue 4, 2015, Pages 489-498

  Can, Güray ^a   Tezel, Ahmet ^b   Gürkan, Hakan ^b   Can, Hatice ^a   Yilmaz, Bülent ^c   Ünsal, Gülbin ^b   Soylu, Ali Riza ^b   Ümit, Hasan Celalettin ^b  

^a ABANT IZZET BAYSAL UNIVERSITY   (Turkey)

^b TRAKYA UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^c Bolu Izzet Baysal State Hospital   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; NEUTROPHIL CYTOPLASMIC ANTIBODY; PROTEIN TYROSINE KINASE; TYROSINE KINASE 2; UNCLASSIFIED DRUG; PROTEIN KINASE TYK2; TYK2 PROTEIN, HUMAN;

ADULT; AGED; ANUS FISTULA; ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CROHN DISEASE; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; POPULATION; REAL TIME POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; TURK (PEOPLE); ULCERATIVE COLITIS; CASE CONTROL STUDY; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; TURKEY; YOUNG ADULT;

ADULT; AGED; CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; REAL-TIME POLYMERASE CHAIN REACTION; TURKEY; TYK2 KINASE; YOUNG ADULT;

EID: 84940893678     PISSN: 22107401     EISSN: 2210741X     Source Type: Journal    
DOI: 10.1016/j.clinre.2015.01.005     Document Type: Article

References (21)

1. Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 1998, 115:182-205.
2. Xavier R.J., Podolsky D.K. Unravelling the pathogenesis of inflammatory bowel disease. Nature 2007, 448:427-434.
3. Cho J.H. The genetics and immunopathogenesis of inflammatory bowel disease. Nat Rev Immunol 2008, 8:458-466.
4. Lakatos P.L., Fischer S., Lakatos L., Gal I., Papp J. Current concept on the pathogenesis of inflammatory bowel disease-crosstalk between genetic and microbial factors: pathogenic bacteria and altered bacterial sensing or changes in mucosal integrity take "toll"?. World J Gastroenterol 2006, 12:1829-1841.
5. Khor B., Gardet A., Xavier R.J. Genetics and pathogenesis of inflammatory bowel disease. Nature 2011, 474:307-317.
6. Kaser A., Zeissig S., Blumberg R.S. Inflammatory bowel disease. Annu Rev Immunol 2010, 28:573-621.
7. Wang K., Zhang H., Kugathasan S., Annese V., Bradfield J.P., Russell R.K., et al. Diverse genome-wide association studies associate the IL12/IL23 pathway with Crohn disease. Am J Hum Genet 2009, 84:399-405.
8. Barrett J.C., Hansoul S., Nicolae D.L., Cho J.H., Duerr R.H., Rioux J.D., et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet 2008, 40:955-962.
9. Franke A., Balschun T., Karlsen T.H., Hedderich J., May S., Lu T., et al. Replication of signals from recent studies of Crohn's disease identifies previously unknown disease loci for ulcerative colitis. Nat Genet 2008, 40:713-715.
10. Abraham C., Cho J.H. IL-23 and autoimmunity: new insights into the pathogenesis of inflammatory bowel disease. Annu Rev Med 2009, 60:97-110.
11. Kikly K., Liu L., Na S., Sedgwick J.D. The IL-23/Th(17) axis: therapeutic targets for autoimmune inflammation. Curr Opin Immunol 2006, 18:670-675.
12. Nakamura R., Shibata K., Yamada H., Shimoda K., Nakayama K., Yoshikai Y. Tyk2-signaling plays an important role in host defense against Escherichia coli through IL-23-induced IL-17 production by gammadelta T cells. J Immunol 2008, 181:2071-2075.
13. Satsangi J., Silverberg M.S., Vermeire S., Colombel J.F. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut 2006, 55:749-753.
14. Sato K., Shiota M., Fukuda S., Iwamoto E., Machida H., Inamine T., et al. Strong evidence of a combination polymorphism of the tyrosine kinase 2 gene and the signal transducer and activator of transcription 3 gene as a DNA-based biomarker for susceptibility to Crohn's disease in the Japanese population. J Clin Immunol 2009, 29:815-825.
15. Franke A., Balschun T., Karlsen T.H., Sventoraityte J., Nikolaus S., Mayr G., et al. Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility. Nat Genet 2008, 40:1319-1323.
16. Tao J.H., Zou Y.F., Feng X.L., Li J., Wang F., Pan F.M., et al. Meta-analysis of TYK2 gene polymorphisms association with susceptibility to autoimmune and inflammatory diseases. Mol Biol Rep 2011, 38:4663-4672.
17. Cunninghame Graham D.S., Akil M., Vyse T.J. Association of polymorphisms across the tyrosine kinase gene, TYK2 in UK SLE families. Rheumatology (Oxford) 2007, 46:927-930.
18. Mero I.L., Lorentzen A.R., Ban M., Smestad C., Celius E.G., Aarseth J.H., et al. A rare variant of the TYK2 gene is confirmed to be associated with multiple sclerosis. Eur J Hum Genet 2010, 18:502-504.
19. International Genetics of Ankylosing Spondylitis C, Cortes A., Hadler J., Pointon J.P., Robinson P.C., Karaderi T., et al. Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci. Nat Genet 2013, 45:730-738.
20. Lees C.W., Barrett J.C., Parkes M., Satsangi J. New IBD genetics: common pathways with other diseases. Gut 2011, 60:1739-1753.
21. Lian L.H., Lau T.P., Lee V.L., Lee W.S., Hilmi I., Goh K.L., et al. Lack of association between TYK2 and STAT3 genes and Crohn's disease in the Malaysian population. Genet Mol Res 2013, 12:167-174.